Zhen-Yi Wang & Zhu Chen: Quite a Combination
There was a time when if you were diagnosed with acute promyelocytic leukemia, or APL, the prognosis was grim. First discovered in 1957, APL is a form of acute myeloid leukemia, where immature white blood cells called promyelocytes accumulate in the bone marrow. The overgrowth of promyelocytes leads to a…...
Changing the Way Drugs Target Cancer
Cancer treatment has evolved greatly in the past fifty years. Since the introduction of chemotherapy, radiation therapy and stem cell transplants, tens of thousands of cancer patients have been victorious in battle. All of these advances have impacted cancer treatment, but a recent drug approval by the U.S. Food and…...
In Remembrance of Sanford “Sandy” Hillsberg
Every day, we are reminded of the impact our donors make on cancer research. We especially remember a uniquely special individual, Mr. Sanford “Sandy” Hillsberg, who passed away on February 19th and is being memorialized in a formal ceremony today. There is a saying, “Being deeply loved by someone gives…...
NFCR Fellow Susan Band Horwitz Receives Canada Gairdner Award
FOR IMMEDIATE RELEASE: April 2, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Canada’s Most Prominent Scientific Prize Honors World’s Biomedical Research Elite ROCKVILLE, MD – Susan Band Horwitz, Ph.D., has today been named one of seven…...
NFCR at the 2019 American Association for Cancer Research Annual Meeting
FOR IMMEDIATE RELEASE: March 28, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Profile Includes Distinguished Public Service Award for Daniel Von Hoff ROCKVILLE, MD – The National Foundation for Cancer Research (NFCR) will be well represented…...
Strategic Media Partner
